Editorial: Chromosome segregation and aneuploidy in cancer

Oscar Molina; Jordi Camps

doi:10.3389/fcell.2023.1353851

Editorial: Chromosome segregation and aneuploidy in cancer

Front Cell Dev Biol. 2023 Dec 22:11:1353851. doi: 10.3389/fcell.2023.1353851. eCollection 2023.

Authors

Oscar Molina^{1

2}, Jordi Camps^{3

4

5}

Affiliations

¹ Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.
² Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain.
³ August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
⁴ Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
⁵ Cell Biology and Medical Genetics Unit, Department of Cell Biology, Physiology and Immunology, Faculty of Medicine, Autonomous University of Barcelona (UAB), Bellaterra, Spain.

No abstract available

Keywords: aneuploidy; cancer; centromere (CEN); chromosomal instability (CIN); whole-genome doubling (WGD).

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. OM is supported by grants from the Spanish Cancer Association (AECC; INVES211226MOLI), the Spanish Ministry of Economy and Competitiveness/European Union NextGenerationEU (PID 2022-142966OB-I00) and the Deustche José Carreras Leukämie-Stiftung (DJCLS 15 R/2023). JC is funded by grants from the Instituto de Salud Carlos III and co-funded by the European Regional Development Fund (ERDF) (PI20/00863), the CIBEREHD program from Instituto de Salud Carlos III, and the Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya (2021 SGR 01427).